OT: Stock and Investment Thread
- Thread starter RU05
- Start date
Price targets raised to the $430 to $450 range. It was an outstanding report. AVGO will be back over $400 in a week or so.
Agreed - this selloff is absurd unless you believe there are 'big money' reasons to "tank it" for a quick money grab on the short play or a reset going into next year. The earnings report was outstanding and this thing will be up near $500 next year. .
Another rug pull on legalization or rescheduling or is this one finally real? If real, TLRY et al have a lot of room to run.
UPDATE: Bought a block of TLRY shares just before the bell. Saw the CNBC article that Trump is likely to sign executive orders for reclassification. Maybe legalization in 2026? I'm using my Fidelity rollover IRA, so I can trade as needed (without tax implications). We shall see!
@rurahrah000
Last edited:
Actually, nothing real. A fake report of an FDA denial was posted on a Yahoo Finance page. It triggered automated selling, but then everyone figured out the info was BS. The stock gained most of the dump back.
FDA news should post sometime on Monday.
Approved!!!
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) | Milestone Pharmaceuticals, Inc.
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT enables development of AFib-RVR under sNDA pathway Milestone well-capitalized to launch and
investors.milestonepharma.com
AMEN! This is going to be interesting on Monday and over the next few weeks. Cardamyst was approved for PSVT which is a relatively smaller patient population. However, the next indication they are working on is A-FIB, which is huge. Getting PSVT approved will now give the street much more confidence that A-FIB is within reach and likely cause a re-rating of the stock.Approved!!!
Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) | Milestone Pharmaceuticals, Inc.
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly resolve episodes of PSVT and restore sinus rhythm FDA approval in PSVT enables development of AFib-RVR under sNDA pathway Milestone well-capitalized to launch and
I am holding MIST Dec 19 $2.5 calls.....which I will probably cash in on Monday. However, not sure what to do with my shares. Hold, trim, or sell. Hmm.....
The 2 indications (one approved, one in development):
Last edited:
Whoever posted it should go to prison it triggered my stop loss. Hello SEC?!?
+1
I'm sure it messed up a bunch of investors. Seemed deliberate, especially on a day of heavy options trading.
Not too much right now on SLS, need to research more. Based on what I know, the AML space is very crowded, but if you can show legit improvement, the market is huge and lucrative (so high risk, high reward). Also, it seems like they will need to raise again in early/mid-2026, so perhaps wait for the dilution dip to buy (or add)?
Phase 2 update coming around this time, so maybe good news and the raise would be announced at the same time? Something to look into.
One last thing, SJS' market cap of $300m is perfect for clinical stage biotech. Not too low that the company is in distress, but not too high that the initial value is already sucked up. Very interesting opportunity!
It's all about that Beta.Junior copper miners? Young man, you have a problem.
Then again, I'm waiting for the FDA decision today or Monday on MIST, so we all have our burden to bear.
My new GLD futures already blowing up!
AVGO = price targets are increasing, major intraday turnaround?
Autonomous.
Rivian unveils ambitious plan to take on autonomous driving
The company’s first step is to bring its Universal Hands-Free system to its second-generation R1 trucks and SUVs, which first rolled off lots in 2024.
www.detroitnews.com
"Electric-vehicle maker Rivian Automotive Inc. unveiled plans to bring more autonomous driving features to its electric vehicles, potentially upending conventional rules of car use and ownership.
At an event in Palo Alto, California, on Thursday, CEO RJ Scaringe laid out the company’s road map, which involves delivering enhanced driver assistance tools to existing vehicles in the coming weeks, followed by a more pronounced technical push throughout 2026 to make future EV models capable of driving without human intervention."
I was able to get in on TLRY at $12.2.....should have bought calls instead.
Is TLRY your preferred cannabis play? Seems like the bellwether of the group.
None of these companies are particularly appealing. TLRY, GTBIF, TCNNF are seemingly the best, but the latter two companies trade OTC. I am not sure How excited you are about trading OTC.I was able to get in on TLRY at $12.2.....should have bought calls instead.
Is TLRY your preferred cannabis play? Seems like the bellwether of the group.
Not that excited since they don’t trade after hours or have options (at least via Fidelity). Maybe TLRY will head back to $200 after Trump legalizes!
Yup JNUG SVM AEM and COPJ all near the top of my board this morningAnd gold keeps gold’ing.
LABU up there too.
Got out of my calls at the opening with a modest gain (only 25-30%). Tons of selling today, so the stock is only up a bit. Long hold with the shares. I see a few nice price target increases, so the trend should be positive.AMEN! This is going to be interesting on Monday and over the next few weeks. Cardamyst was approved for PSVT which is a relatively smaller patient population. However, the next indication they are working on is A-FIB, which is huge. Getting PSVT approved will now give the street much more confidence that A-FIB is within reach and likely cause a re-rating of the stock.
I am holding MIST Dec 19 $2.5 calls.....which I will probably cash in on Monday. However, not sure what to do with my shares. Hold, trim, or sell. Hmm.....
The 2 indications (one approved, one in development):
Last edited:
Zillow getting crushed thanks to Google. I’d consider nibbling because I think Zillow is an industry leader …unless AI kills it once someone can give the prompt “show me all houses for sale in Stone Harbor that meet the following criteria…” At that point you may not need Zillow as the front door to listings.
It's dirt cheap on PE and just started selling H200's to China with Trump's blessing.
Not so sure about the end of the year rally anymore…wish I sold a few weeks back. Hoping for a run up before year end….
Any thoughts on SOUN? Been slowly adding to this position. Trying to find the next PLTR.
The market is like 1% off of ATH. Feels worse, but we are still right there.
Got it. I'm definitely a lean to growth/AI, but even my personal/fun account has some good diversity - SLB, SBUX, NKE calls. Financials and a few health care stocks.
From Fidelity:
Exclusive-Nasdaq seeks to extend trading hours, as Wall Street gears up for 24/7 move
Exclusive-Nasdaq seeks to extend trading hours, as Wall Street gears up for 24/7 move
If NVDA collapses the market will tank. I do think competition is red hot which is concerning long term.
You had to buy SLB didn't you. It was $40+ last Thursday and now.....
But I did buy this oil dip (XLE $45 calls Jan 2027).
Last edited:
No I don’t have any intel to n that.Any thoughts on SOUN? Been slowly adding to this position. Trying to find the next PLTR.
I wasn't paying attention the last couple days, I'm down 6% like that.You had to buy SLB didn't you. It was $40+ last Thursday and now.....
But I did buy this oil dip (XLE $45 calls Jan 2027).
I bought some DVN as well, also down on that, but it is bouncing a little nicer today.
The downside moves didn't break the upward trend, yet at least. Charts still look productive.
I have room to add to SLB so I probably will.